← Back to Search

Acupuncture for Urinary Issues in Prostate Cancer Survivors

Phase 1 & 2
Recruiting
Led By Kevin Liou, MD
Research Sponsored by Memorial Sloan Kettering Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Clinically meaningful nocturia, defined as ≥2 nocturia episodes every night for the past month
Age 18 or older
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights

Study Summary

This trial will study whether acupuncture can help reduce nocturia in prostate cancer survivors.

Who is the study for?
This trial is for prostate cancer survivors over 18 with no current evidence of cancer, experiencing frequent nighttime urination (nocturia). They must not have started new urinary medications or changed doses in the last month and can't have untreated sleep disorders, psychiatric conditions, or be at high risk for obstructive sleep apnea.Check my eligibility
What is being tested?
The study tests if acupuncture can help reduce nocturia in prostate cancer survivors. It's a first-of-its-kind study to see if this traditional technique could also ease insomnia, hot flashes, anxiety, depression, fatigue, sexual dysfunction and cognitive issues related to prostate cancer survivorship.See study design
What are the potential side effects?
Acupuncture may cause minor side effects such as soreness or bruising at needle sites. More serious side effects are rare but can include infections or injury from needles.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I wake up to urinate 2 or more times every night for the last month.
Select...
I am 18 years old or older.
Select...
I have been diagnosed with prostate cancer before.
Select...
I do not have prostate cancer.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
success

Side effects data

From 2013 Phase 1 & 2 trial • 104 Patients • NCT01305811
2%
Serious unexpected
2%
Pain on needling
100%
80%
60%
40%
20%
0%
Study treatment Arm
Bi-Weekly Acupuncture
Wait List

Trial Design

2Treatment groups
Experimental Treatment
Group I: Waitlist ControlExperimental Treatment2 Interventions
The waitlist control group will not receive any acupuncture treatments during the 14-week waiting period. Patients in waitlist control group will have the option to receive up to 10 acupuncture treatments after a 14-week waiting period.
Group II: AcupunctureExperimental Treatment2 Interventions
Acupuncture group will receive 10 treatments of acupuncture over the course of 10 weeks (i.e. one treatment a week) with a +/- 14-day window.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Acupuncture
2011
Completed Phase 3
~1240

Find a Location

Who is running the clinical trial?

Memorial Sloan Kettering Cancer CenterLead Sponsor
1,930 Previous Clinical Trials
597,318 Total Patients Enrolled
131 Trials studying Prostate Cancer
65,834 Patients Enrolled for Prostate Cancer
Kevin Liou, MDPrincipal InvestigatorMemorial Sloan Kettering Cancer Center

Media Library

Acupuncture Clinical Trial Eligibility Overview. Trial Name: NCT05540392 — Phase 1 & 2
Prostate Cancer Research Study Groups: Acupuncture, Waitlist Control
Prostate Cancer Clinical Trial 2023: Acupuncture Highlights & Side Effects. Trial Name: NCT05540392 — Phase 1 & 2
Acupuncture 2023 Treatment Timeline for Medical Study. Trial Name: NCT05540392 — Phase 1 & 2

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any remaining vacancies in this research endeavor?

"Affirmative. Clinicaltrials.gov indicates that enrollment for this clinical trial is happening now, with the listing first posted on September 9th 2022 and updated lastly on November 9th 2022. 60 participants from 8 different medical centres are being recruited by the research team."

Answered by AI

What is the enrollment capacity of this medical experiment?

"Yes, according to clinicaltrials.gov the trial which opened on September 9th 2022 is still actively recruiting participants. Currently, 8 different medical centres need 60 patients for this investigation."

Answered by AI

How wide-reaching is the availability of this clinical experiment?

"8 clinical trial sites are operational for this particular medical experiment, including Memorial Sloan Kettering Bergen in Montvale, Memorial Sloan Kettering Cancer Center Suffolk - Commack in Commack and Memorial Sloan Kettering Westchester in Harrison. Additionally, there are a further 5 enrolment locations."

Answered by AI
~13 spots leftby Sep 2024